Consulting and governance portfolio has been an avenue for values and knowledge translation in the 3 spheres of Introspection (incl setting vission-values-strategy, deep-futures-systems thinking), Innovation (incl bio-tech, translation, SIT policy) and Impact (outcomes measurement). Functional expertise in strategy and policy development, new product development, fundraising and business development, commercialisation, due diligence, capability building, outcomes monitoring and reporting.
Strengths:
Markets: NZ, UK, India, US, Singapore
Sectors: Advanced Tech (incl. Biotech, Healthtech, Agritech, Medtech), Pharmaceuticals, Public sector, Financial Services
Stage : Conception, Research Commercialisation and Innovation Strategy, Systems Transformation
Advisory and governance roles listed in Bio page
Clients/ Projects (further details on some projects on Knowledge page)
MBIE NZ Institute of Advanced Technologies on establishment and synthetic biology
Malaghan Institute of Medical Research on 2030 strategy development, CAR-T cell Phase 2 clinical trial fundraising strategy with philanthropists, government funding strategy and reporting, and translation research capacity building
NZ RNA Platform on benchmarking, translation research capability building, developing flagship project/s and reporting
Kiwinet on developing commercial aspiration and core capability through the Emerging Innovator Programme
BioPacific Partners on public health, agritech, animal health and foodtech strategy and innovation partnerships with global MNCs and government
Independent consulting projects in NZ and UK also with Impact Lab, Bactevo, and Comvita
